Evidence map›Paper›PMID 33824317›Full record

ArticleNature communications2021

Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage.

Zhongbo Chen, David Zhang, Regina H Reynolds, Emil K Gustavsson, Sonia García-Ruiz, Karishma D'Sa, Aine Fairbrother-Browne, Jana Vandrovcova, International Parkinson’s Disease Genomics Consortium (IPDGC), John Hardy and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Long-Read epigenetic clocks identify improved brain aging predictions.bioRxiv : the preprint server for biology · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 20 institutions in 13 countries.

Zhongbo ChenDepartment of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
David ZhangDepartment of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
Regina H ReynoldsDepartment of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.ORCID 0000-0001-6470-7919
Emil K GustavssonDepartment of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.ORCID 0000-0003-0541-7537
Sonia García-RuizDepartment of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
Karishma D'SaDepartment of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
Aine Fairbrother-BrowneDepartment of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
Jana VandrovcovaDepartment of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
International Parkinson’s Disease Genomics Consortium (IPDGC)
John HardyDepartment of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
Henry HouldenDepartment of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.ORCID 0000-0002-2866-7777
Sarah A Gagliano TaliunDepartment of Medicine & Department of Neurosciences, Université de Montréal, Université de Montréal, Montréal, QC, Canada.ORCID 0000-0003-1306-1868
Juan BotíaDepartment of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
Mina RytenDepartment of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK. mina.ryten@ucl.ac.uk.ORCID 0000-0001-9520-6957
National Hospital for Neurology and Neurosurgery · GBInstituto de Biomedicina de Sevilla · ESHospital Clínic de Barcelona · ESGreat Ormond Street Hospital · GBNational Institute on Aging · USGerman Center for Neurodegenerative Diseases · DEUniversity Hospital Mútua de Terrassa · ESBiogipuzkoa Health Research Institute · ESHospital Universitario Central de Asturias · ESInstituto de Investigación Marqués de Valdecilla · ESUniversitat Autònoma de Barcelona · ESCentre National de la Recherche Scientifique · FRUniversidad de Granada · ESHospital General De Segovia · ESHospital Universitario Ramón y Cajal · ESMontreal Neurological Institute and Hospital · CAUniversity of Liverpool · GBBaylor College of Medicine · USCardiff University · GBHospital Clínico Universitario Virgen de la Victoria · ES

Funding

Genetic characterization of atypical parkinsonismZIANS003154 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI SCHOLZ, SONJA · 2016 to 2025
$15.4M
Department of HealthMedical Research Council G0701075Medical Research Council G0901254Medical Research Council G1001253Medical Research Council MR/J004758/1Medical Research Council MR/K01417X/1Medical Research Council MR/L501542/1Medical Research Council MR/N008324/1Medical Research Council MR/N026004/1Parkinson's UK G-0907Parkinson's UK G-1307Wellcome Trust 202903/Z/16/Z
6 · The paper itself

Abstract

Knowledge of genomic features specific to the human lineage may provide insights into brain-related diseases. We leverage high-depth whole genome sequencing data to generate a combined annotation identifying regions simultaneously depleted for genetic variation (constrained regions) and poorly conserved across primates. We propose that these constrained, non-conserved regions (CNCRs) have been subject to human-specific purifying selection and are enriched for brain-specific elements. We find that CNCRs are depleted from protein-coding genes but enriched within lncRNAs. We demonstrate that per-SNP heritability of a range of brain-relevant phenotypes are enriched within CNCRs. We find that genes implicated in neurological diseases have high CNCR density, including APOE, highlighting an unannotated intron-3 retention event. Using human brain RNA-sequencing data, we show the intron-3-retaining transcript to be more abundant in Alzheimer's disease with more severe tau and amyloid pathological burden. Thus, we demonstrate potential association of human-lineage-specific sequences in brain development and neurological disease.

Indexed as

Genome, HumanPhylogenyAlzheimer DiseaseApolipoproteins EBrainChromosomes, Human, Pair 19Conserved SequenceDNA, IntergenicGene OntologyHumansIntronsLinkage DisequilibriumMolecular Sequence AnnotationNeurodegenerative DiseasesPhenotypePolymorphism, Single NucleotideApolipoproteins EDNA, IntergenicRNA, Long NoncodingRNA, Messenger

Identifiers

PMID33824317
PMCPMC8024253
OpenAlexW3144896771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.